| 类风湿关节炎相关间质性肺疾病预后影响因素的研究进展 |
| |
| 引用本文： | 陈梁欣,彭翔.类风湿关节炎相关间质性肺疾病预后影响因素的研究进展[J].中国处方药,2022(1). |
| |
| 作者姓名： | 陈梁欣 彭翔 |
| |
| 作者单位： | 广州医科大学研究生院;深圳市南山区蛇口人民医院;清远市人民医院 |
| |
| 摘 要： | 类风湿关节炎相关间质性肺疾病(RA-ILD)目前无公认的治疗方案,需要权衡治疗的获益和风险,因此,准确的评估和判断患者预后有助于指导临床治疗、优化医疗资源配置、减轻社会经济负担。本文将对目前发现的影响RA-ILD患者临床预后的相关因素以及药物治疗新进展进行总结。
|
| 关 键 词： | 类风湿关节炎相关间质性肺疾病 预后因素 综述 |
Research advance on prognostic determinants in patients with rheumatoid arthritis-associated interstitial lung disease |
| |
| Authors: | CHEN Liang-xin PENG Xiang |
| |
| Institution: | (Graduate School of Guangzhou Medical University,Guangzhou 510182,China;不详) |
| |
| Abstract: | For now,there is no approved treatments for rheumatoid arthritis-associated interstitial lung disease(RA-ILD),and the benefits and risks of treatment need to be well balanced before therapy.Therefore,accurate assessment and prognosis judgement are helpful to guide clinical treatment,optimize medical resource allocation,and reduce social and economic burden.In this paper,the related factors affecting the clinical prognosis of patients with RA-ILD and new advances in drug therapy were summarized. |
| |
| Keywords: | Rheumatoid arthritis-associated interstitial lung disease Prognostic factor Review |
| 本文献已被 维普 等数据库收录！ |
